Topics

Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests

2019-10-18 11:21:42 | BioPortfolio

Summary

This is a single site, prospective, cross-sectional, controlled clinical study on a total of 66 subjects. The subjects are divided into two groups: Hypertonic Saline Non-Responders (33 subjects) and Hypertonic Saline Responders (33 subjects). After completion of questionnaires, the subjects will undergo Dry Eye Disease testing and functional nerve testing. Subjects who qualify will be dispensed 4 weeks of preservative free artificial tears and instructed to instill one drop into each eye twice daily. Subjects will return for a follow up visit 4 weeks later (± 4 days), during which subjects will complete the questionnaires again and the Dry Eye Disease tests and functional nerve tests will be repeated.

Study Design

Conditions

Dry Eye

Intervention

Preservative-free Refresh Optive Advanced Lubricant Eye Drops

Location

Tufts Medical Center-New England Eye Center
Boston
Massachusetts
United States
02111

Status

Recruiting

Source

Tufts Medical Center

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-10-18T11:21:42-0400

Clinical Trials [1020 Associated Clinical Trials listed on BioPortfolio]

Clinical Outcomes Following Treatment With SYSTANE® BALANCE

The purpose of this study is to evaluate the clinical effectiveness of SYSTANE® BALANCE compared to REFRESH OPTIVE® Advanced in subjects with lipid-deficient dry eye.

Safety/Efficacy of Systane Free vs Refresh Liquigel

The objective of this study is to evaluate the safety and efficacy of Systane Free FID 105783 in comparison to Refresh Liquigel Lubricant Eye Drops (Allergan) in a specified population of ...

Safety/Efficacy of Systane Free vs Refresh Tears

The objective of this study is to evaluate the safety and efficacy of Systane Free FID 105783 in comparison to Refresh Tears Lubricant Eye Drops (Allergan) in a specified population of dry...

Acute Comfort of Lubricant Eye Drops FID 112903

To evaluate the acute comfort and blurring profile between two artificial tears in dry eye patients.

The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance

To evaluate the effect of 2 different lubricant eye drops on visual function of patients with dry eye

PubMed Articles [8710 Associated PubMed Articles listed on BioPortfolio]

Medical devices biocompatibility assessment on HCE: Evidences of delayed cytotoxicity of preserved compared to preservative free eye drops.

A multiple endpoint analysis (MEA) approach on human reconstructed corneal epithelium (HCE) model has been applied to assess the biocompatibility (cytotoxicity and irritation potential) of medical dev...

An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial.

To evaluate the efficacy and safety of a nano-emulsion artificial tear (OM3) containing carboxymethylcellulose (CMC) and glycerin, flaxseed oil and castor oil, and three osmoprotectants (levocarnitine...

Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension.

PRéCIS:: Noninferiority of efficacy was demonstrated for a preservative-free latanoprost-timolol fixed combination compared with a BAK-containing formulation at 84 days after treatment in patients wi...

Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives.

Preservative selection is a critical step in the preparation of a formulation to ensure its microbiological effectiveness and stability. A number of physicochemical factors must be considered when sel...

Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues.

To investigate the usefulness of meibomian gland (MG) dropout rate in the evaluation of MG morphological change associated with the use of prostaglandin for glaucoma treatment through the association ...

Medical and Biotech [MESH] Definitions

Ophthalmic solutions that include LUBRICANTS and WETTING AGENTS such as POLYETHYLENE GLYCOL; HYPROMELLOSE; GLYCEROL; PROPYLENE GLYCOL. They are used to treat conditions caused by deficient tear production such as DRY EYE SYNDROME.

The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from irrigation in that the irrigate is removed within minutes, but the instillate is left in place.

Advanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialized medical/surgical procedures as well as advanced diagnostic and therapeutic equipment.

The use of sophisticated methods and equipment to treat cardiopulmonary arrest. Advanced Cardiac Life Support (ACLS) includes the use of specialized equipment to maintain the airway, early defibrillation and pharmacological therapy.

A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.

More From BioPortfolio on "Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests"

Quick Search

Searches Linking to this Trial